Compare Mutual Funds
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
2.49
-
NAV
₹505.95
-
Fund Started
10 May 2004
-
Fund Size
₹7898.24 Cr
-
Exit Load
Exit load of 1% if redeemed within 1 month.
-
1 Year
2.11%
-
3 Year
21.53%
-
5 Year
13.06%
-
Equity
99.45%
-
Cash
0.54%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.92% |
Lupin Ltd. | 8.45% |
Divi's Laboratories Ltd. | 6.41% |
Dr. Reddy's Laboratories Ltd. | 5.96% |
Cipla Ltd. | 5.42% |
Apollo Hospitals Enterprise Ltd. | 5.15% |
Medplus Health Services Ltd. | 3.86% |
Ajanta Pharma Ltd. | 3.36% |
Max Healthcare Institute Ltd. | 3.24% |
Vijaya Diagnostic Centre Ltd. | 3.15% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
-
Launch Date
10 May 2004
-
